Novel Personalized Non Invasive Combined Magnetic and Electrical Stimulation of the DMN in Mild AD Patients
RecruitingNCT07075770Phase: NAStarted 2025-01-01
Summary
Alzheimer's disease (AD) is increasingly recognized as a disorder marked by early synaptic dysfunction and disrupted brain network connectivity, beyond the traditional focus on amyloid pathology. Syna
Eligibility
Sex
ALL
Min Age
50 Years
Max Age
85 Years
Locations
IRCCS Santa Lucia FoundationRome, Italy, Italy
I.R.C.C.S. Centro Neurolesi Bonino PulejoMessina, Sicily, Italy
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07075770